glp-1 pharmaceuticals As Interest in Drugs Spikes, Employers Weigh the Costs, Benefits The GLP-1 Drugs Revolution: How

BPC-157 emerges as a promising therapeutic peptide for improving bone and joint good health

We thank Dr Mikhail A Kozhuhov, Dr Dmitriy Ushachev, Dr Alexender Shestakov and Dr Olga Kolesnikova from Kursk Regional Clinical Hospital, and Dr Vladimir E Ivakin, Dr Ludmila Katargina from Kursk Emergency Medicine Hospital for their assistance in patient recruitment

Regular monitoring allows us to intervene early if we detect concerning patterns

If you're trying to decide which supplements might be right for your health and nutrition needs, a quiz might help

JHU395 can prolong the median survival of mice bearing human MYC-amplified medulloblastoma xenografts from 26 to 45 days (Pham et al., 2021)

The prevalence of HFpEF is rising, increasing from 33 to 39% between 2005 and 2010, with projections suggesting it will soon become the most common form of HF [5, 6]